NORD Files Amicus Brief to Protect Drug Development Incentives in the Orphan Drug Act
Washington, D.C., July 30, 2015 – The National Organization for Rare Disorders (NORD) has filed an amicus brief in the D.C. Circuit of the U.S. Court of Appeals, stating that a …
Read more